A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection

Transfusion

Volumn 50, Issue 1, 2010, Pages 208-212

  Rossi, Fernanda C ^a,b,c,d   Angerami, Rodrigo N ^a,b,c,d   De Paula, Erich V ^a,b,c,d   Orsi, Fernanda L ^a,b,c,d   Shang, Dezhi ^a,b,c,d   Del Guercio, Vânia M ^a,b,c,d   Resende, Mariângela R ^a,b,c,d   Annichino Bizzacchi, Joyce M ^a,b,c,d   Da Silva, Luiz J ^a,b,c,d   Zheng, X Long ^a,b,c,d   Castro, Vagner ^a,b,c,d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; THROMBOCYTE ANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CASE REPORT; DENGUE; DENGUE VIRUS; DISEASE COURSE; FEVER; FOLLOW UP; HEADACHE; HUMAN; LEG; MALE; MELENA; PETECHIA; PLASMAPHERESIS; REMISSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE DISEASE; ADAM PROTEINS; AUTOANTIBODIES; BLOOD PLATELETS; DENGUE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PLASMA EXCHANGE; THROMBOTIC MICROANGIOPATHIES;

EID: 73649134338     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02391.x     Document Type: Article

References (25)

1. Guzman MG. Global voices of science. Deciphering dengue: the Cuban experience. Science 2005 309 : 1495 7.
2. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998 352 : 971 7.
3. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002 2 : 33 42.
4. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjørup I, Lopez-Velez R, Clerinx J, Peyerl-Hoffmann G, Sundøy A, Genton B, Kern P, Calleri G, de Górgolas M, Mühlberger N, Jelinek T European Network on Surveillance of Imported Infectious Diseases. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis 2007 195 : 1089 96.
5. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, Yang TI, Sheu FC, Kuo CF, Lin YS. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001 63 : 143 9.
6. Rigau-Perez JG. Severe dengue: the need for new case definitions. Lancet Infect Dis 2006 6 : 297 302.
7. Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 2008 3 : 249 77.
8. WHO. Technical manual: dengue haemorrhagic fever: diagnosis treatment, prevention and control. Geneva : World Health Organization 1997.
9. Kok RH, Wolfhagen MJ, Klosters G. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin Infect Dis 2001 32 : 311 2.
10. Yagita M, Uemura M, Nakamura T, Kunitomi A, Matsumoto M, Fujimura Y. Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura. J Hepatol 2005 42 : 420 1.
11. Fenner M, Frankenberger R, Pressmar K, John S, Neukam FW, Nkenke E. Life-threatening thrombotic thrombocytopenic purpura associated with dental foci. Report of two cases. J Clin Periodontol 2004 31 : 1019 23.
12. Morrin MJ, Jones FG, McConville J, Arnold C, Mullan B, Lavery GG, McMullin MF. Thrombotic thrombocytopenic purpura secondary to Streptococcus. Transfus Apher Sci 2006 34 : 153 5.
13. Gunther K, Garizio D, Nesara P. ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura. Transfusion 2007 47 : 1710 6.
14. Brecher ME, Hay SN, Park YA. Is it HIV TTP or HIV-associated thrombotic microangiopathy? J Clin Apher 2008 23 : 186 90.
15. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody - specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987 70 : 1722 6.
16. Castro V, Kroll H, Origa AF, Falconi MA, Marques SB, Marba ST, Passini R Jr., Annichino-Bizzacchi JM, Costa FF, Santoso S, Arruda VR. A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns. Transfusion 2007 47 : 59 66.
17. Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999 82 : 1386 9.
18. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005 129 : 93 100.
19. Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004 407 23.
20. Allford SL, Hunt BJ, Rose P, Machin SJ. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003 120 : 556 73.
21. Halstead SB. Dengue. Lancet 2007 370 : 1644 52.
22. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006 19 : 429 36.
23. Ramasubbu K, Mullick T, Koo A, Hussein M, Henderson JM, Mullen KD, Avery RK. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis 2003 5 : 98 103.
24. Sun DS, King CC, Huang HS, Shih YL, Lee CC, Tsai WJ, Yu CC, Chang HH. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost 2007 5 : 2291 9.
25. Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007 97 : 627 34.